US Patent 10829481 Benzimidazole derivatives as modulators of ROR-gamma
Patent 10829481 was granted and assigned to Vitae Pharmaceuticals on November, 2020 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
January 27, 2017
Date of Patent
November 10, 2020
Patent Applicant
Patent Application Number
16073503
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10829481 Benzimidazole derivatives as modulators of ROR-gamma
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.